T

True North Therapeutics

50 employees

True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Clinical Trials

Date founded

2013

Funding rounds raised

Total raised

$45M

from 19 investors over 19 rounds

T

True North Therapeutics raised undisclosed on January 1, 2018

Investors: Mission BioCapital

T

True North Therapeutics raised $45M on October 18, 2016

Investors: Redmile Group, Perceptive Advisors and S.R. One Ltd

T

True North Therapeutics raised $40M on December 3, 2015

Investors: Baxalta, Kleiner Perkins, S.R. One Ltd, New Leaf Venture Partners, Perceptive Advisors, OrbiMed Advisors and MPM Capital

T

True North Therapeutics raised $35M on April 7, 2015

Investors: Kleiner Perkins, S.R. One Ltd, OrbiMed Advisors and MPM Capital

T

True North Therapeutics raised $22M on June 17, 2014

Investors: Biogen Idec, Kleiner Perkins, S.R. One Ltd and MPM Capital

FAQ